Programmable biology, engineered

Programmable cellular systems for infectious disease.

A privately held biotechnology company designing precision biological systems for infectious disease across human and animal health. The intellectual property the company generates is its principal asset. Commercial routes to market are pursued through partnership.

01 / Architecture

Computational design

Machine-readable representations of cellular designs, built on SBOL3 and extended through the Nanomedicine Design Stack.

Learn more →

02 / Systems

Programmable cell chassis

Host cells engineered as platforms for therapeutic circuits, with specificity, safety and traceability designed in from the outset.

Learn more →

03 / Standards

Reproducibility

The design and documentation infrastructure that precision biological medicine needs to be trustworthy at scale.

Learn more →

What we do

Cellular systems engineered to act inside a living organism.

Noviota develops programmable therapeutic platforms for infectious disease. The work spans human medicine, veterinary medicine and livestock health, including One Health interventions where the same pathogen crosses species.

The design layer is built on SBOL3 and extended through the Nanomedicine Design Stack: a structured representation that supports reproducibility, regulatory translation and computational learning.

Noviota owns the intellectual property it generates. Partners deliver experimental validation, manufacturing and clinical translation.

  • Programmable cellular agents

    Therapeutic platforms designed at the molecular scale.

  • Infectious disease focus

    Configurable against specific pathogens, deployable at speed.

  • Human and animal health

    Single-species and One Health applications across both human and veterinary medicine.

One man’s ‘magic’ is another man’s engineering.

Robert A. Heinlein · Time Enough for Love · 1973

Latest writing

Articles, analysis and white papers.

Published work from Noviota on synthetic biology, infectious disease and the design infrastructure behind precision medicine.